BioLineRx to Conduct Interim Analysis of Phase II/III CLARITY Trial of BL-1020

News   Oct 29, 2012

 
BioLineRx to Conduct Interim Analysis of Phase II/III CLARITY Trial of BL-1020
 
 
 
FURTHER INFORMATION
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE